Medical Device News Magazine

Dräger Secures FDA 510(k) Clearance for Evita V600, V800 and Babylog VN800 Ventilators

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Dräger announced today that it received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Evita V600, V800, and Babylog VN800, its newest devices for mechanical ventilation of adults to premature babies. Dräger has developed an operating concept that makes device orientation easier and provides clear user guidance. The user is guided through the individual menus with larger icons, important functions at the top menu level, and a clear, color-coordinated screen design. The lower number of colors for the screen elements and the reduced use of signal colors enable clear, smooth navigation. The bright screen background also minimizes disruptive reflections of ambient light. Clearly structured device checks help safely prepare for the next patient.

“We developed the Evita and Babylog family of devices to meet customer demand for effective and safe mechanical ventilation that is both easy to use and cost-conscious,” said Steve Menet, Senior Vice President of Sales for Hospital Solutions at Draeger, Inc. “This launch takes us a step closer to our goal of providing added value for clinical personnel and patients while simultaneously optimizing costs in the hospital.”

Proven ventilation technology protects patients

Over one hundred years of Dräger experience in ventilation flowed into the technology. It is the basis for efficient therapy options, which can simultaneously improve patient safety. The early support of spontaneous breathing can also help the patient regain mobility more quickly.

Infection prevention requirements considered

To maintain the infection management chain in the hospital, medical devices must support the requirements of hygienically sensitive areas in hospitals. As a result, the new Dräger ventilators not only have a rounded design with few edges and overhangs, but they also have surfaces that can be effectively disinfected. The glass touchscreen on the devices, as an almost seamless screen, also supports the daily hygiene routine at the intensive care workstation.

The Evita V600, Evita V800, and Babylog VN800 ventilators are manufactured by Drägerwerk AG & Co. KGaA.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”